These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 31261774)

  • 1. Renin Activity in Heart Failure with Reduced Systolic Function-New Insights.
    Sullivan RD; Mehta RM; Tripathi R; Reed GL; Gladysheva IP
    Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31261774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normalizing Plasma Renin Activity in Experimental Dilated Cardiomyopathy: Effects on Edema, Cachexia, and Survival.
    Sullivan RD; Mehta RM; Tripathi R; Gladysheva IP; Reed GL
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31404946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Low-Sodium Diet Boosts Ang (1-7) Production and NO-cGMP Bioavailability to Reduce Edema and Enhance Survival in Experimental Heart Failure.
    Tripathi R; Sullivan RD; Fan TM; Mehta RM; Gladysheva IP; Reed GL
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33919841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma renin activity in patients with heart failure and reduced ejection fraction on optimal medical therapy.
    Nijst P; Verbrugge FH; Martens P; Bertrand PB; Dupont M; Francis GS; Tang WW; Mullens W
    J Renin Angiotensin Aldosterone Syst; 2017; 18(3):1470320317729919. PubMed ID: 28875746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertension in Patients with Heart Failure with Reduced Ejection Fraction.
    Volpe M; Santolamazza C; Tocci G
    Curr Cardiol Rep; 2016 Dec; 18(12):127. PubMed ID: 27796865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination Therapy of Renin Angiotensin System Inhibitors and β-Blockers in Patients with Heart Failure.
    Nochioka K; Sakata Y; Shimokawa H
    Adv Exp Med Biol; 2018; 1067():17-30. PubMed ID: 29542073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble (Pro)Renin Receptor Levels Are Regulated by Plasma Renin Activity and Correlated with Edema in Mice and Humans with HFrEF.
    Gladysheva IP; Sullivan RD; Ramanathan K; Reed GL
    Biomedicines; 2022 Aug; 10(8):. PubMed ID: 36009420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of renin and prorenin in heart failure patients with decreased kidney function.
    Szymanski MK; Damman K; van Veldhuisen DJ; van Gilst WH; Hillege HL; de Boer RA
    Am Heart J; 2011 Sep; 162(3):487-93. PubMed ID: 21884865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renin-Angiotensin System Inhibition, Worsening Renal Function, and Outcome in Heart Failure Patients With Reduced and Preserved Ejection Fraction: A Meta-Analysis of Published Study Data.
    Beldhuis IE; Streng KW; Ter Maaten JM; Voors AA; van der Meer P; Rossignol P; McMurray JJ; Damman K
    Circ Heart Fail; 2017 Feb; 10(2):. PubMed ID: 28209765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renin-angiotensin-aldosterone system inhibitors in heart failure.
    Shearer F; Lang CC; Struthers AD
    Clin Pharmacol Ther; 2013 Oct; 94(4):459-67. PubMed ID: 23852393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The predictability of renin-angiotensin-aldosterone system factors for clinical outcome in patients with acute decompensated heart failure.
    Nakada Y; Takahama H; Kanzaki H; Sugano Y; Hasegawa T; Ohara T; Amaki M; Funada A; Yoshida A; Yasuda S; Ogawa H; Anzai T
    Heart Vessels; 2016 Jun; 31(6):925-31. PubMed ID: 25964073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure.
    Mentz RJ; Stevens SR; DeVore AD; Lala A; Vader JM; AbouEzzeddine OF; Khazanie P; Redfield MM; Stevenson LW; O'Connor CM; Goldsmith SR; Bart BA; Anstrom KJ; Hernandez AF; Braunwald E; Felker GM
    JACC Heart Fail; 2015 Feb; 3(2):97-107. PubMed ID: 25543972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of the renin-angiotensin-aldosterone system inhibition on myocardial function in early and late phases of dilated cardiomyopathy in Tgaq*44 mice.
    Woźniak M; Tyrankiewicz U; Drelicharz L; Skórka T; Jabłońska M; Heinze-Paluchowska S; Chłopicki S
    Kardiol Pol; 2013; 71(7):730-7. PubMed ID: 23907907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of plasma renin activity in heart failure.
    Vergaro G; Emdin M; Iervasi A; Zyw L; Gabutti A; Poletti R; Mammini C; Giannoni A; Fontana M; Passino C
    Am J Cardiol; 2011 Jul; 108(2):246-51. PubMed ID: 21545993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined use of direct renin inhibitor and carvedilol in heart failure with preserved systolic function.
    Badheka AO; Tuliani TA; Rathod A; Ali Kizilbash M; Bharadwaj A; Afonso L
    Med Hypotheses; 2012 Oct; 79(4):448-51. PubMed ID: 22800805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refractory hyperaldosteronism in heart failure is associated with plasma renin activity and angiotensinogen polymorphism.
    Vergaro G; Fatini C; Sticchi E; Vassalle C; Gensini G; Ripoli A; Rossignol P; Passino C; Emdin M; Abbate R
    J Cardiovasc Med (Hagerstown); 2015 Jun; 16(6):416-22. PubMed ID: 25036270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct renin inhibition in addition to or as an alternative to angiotensin converting enzyme inhibition in patients with chronic systolic heart failure: rationale and design of the Aliskiren Trial to Minimize OutcomeS in Patients with HEart failuRE (ATMOSPHERE) study.
    Krum H; Massie B; Abraham WT; Dickstein K; Kober L; McMurray JJ; Desai A; Gimpelewicz C; Kandra A; Reimund B; Rattunde H; Armbrecht J;
    Eur J Heart Fail; 2011 Jan; 13(1):107-14. PubMed ID: 21169387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma renin activity is a strong and independent prognostic indicator in patients with acute decompensated heart failure treated with renin-angiotensin system inhibitors.
    Ueda T; Kawakami R; Nishida T; Onoue K; Soeda T; Okayama S; Takeda Y; Watanabe M; Kawata H; Uemura S; Saito Y
    Circ J; 2015; 79(6):1307-14. PubMed ID: 25753468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers of activation of renin-angiotensin-aldosterone system in heart failure: how useful, how feasible?
    Emdin M; Fatini C; Mirizzi G; Poletti R; Borrelli C; Prontera C; Latini R; Passino C; Clerico A; Vergaro G
    Clin Chim Acta; 2015 Mar; 443():85-93. PubMed ID: 25445411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of additive renin inhibition with aliskiren on renal blood flow in patients with Chronic Heart Failure and Renal Dysfunction (Additive Renin Inhibition with Aliskiren on renal blood flow and Neurohormonal Activation in patients with Chronic Heart Failure and Renal Dysfunction).
    Schroten NF; Damman K; Hemmelder MH; Voors AA; Navis G; Gaillard CA; van Veldhuisen DJ; Van Gilst WH; Hillege HL
    Am Heart J; 2015 May; 169(5):693-701.e3. PubMed ID: 25965717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.